BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 19378354)

  • 1. Systematic reviews of economic evaluations: utility or futility?
    Anderson R
    Health Econ; 2010 Mar; 19(3):350-64. PubMed ID: 19378354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
    Manchikanti L
    Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using economic evidence in clinical practice.
    Stone PW
    J Med Pract Manage; 2002; 17(5):272-7. PubMed ID: 12024866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria.
    Evers S; Goossens M; de Vet H; van Tulder M; Ament A
    Int J Technol Assess Health Care; 2005; 21(2):240-5. PubMed ID: 15921065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conducting systematic reviews of economic evaluations.
    Gomersall JS; Jadotte YT; Xue Y; Lockwood S; Riddle D; Preda A
    Int J Evid Based Healthc; 2015 Sep; 13(3):170-8. PubMed ID: 26288063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between economic evaluations and HIV and AIDS treatment policies.
    Taleski SJ; Ahmed K; Whiteside A
    Curr Opin HIV AIDS; 2010 May; 5(3):204-9. PubMed ID: 20539075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expensive care - a rationale for economic evaluations in intensive care.
    Higgins AM; Pettila V; Bellomo R; Harris AH; Nichol AD; Morrison SS
    Crit Care Resusc; 2010 Mar; 12(1):62-6. PubMed ID: 20196716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How useful are systematic reviews of child obesity interventions?
    Wolfenden L; Wiggers J; Tursan d'Espaignet E; Bell AC
    Obes Rev; 2010 Feb; 11(2):159-65. PubMed ID: 19573051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AHRQ series paper 1: comparing medical interventions: AHRQ and the effective health-care program.
    Slutsky J; Atkins D; Chang S; Sharp BA
    J Clin Epidemiol; 2010 May; 63(5):481-3. PubMed ID: 18834715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHRQ series paper 2: principles for developing guidance: AHRQ and the effective health-care program.
    Helfand M; Balshem H
    J Clin Epidemiol; 2010 May; 63(5):484-90. PubMed ID: 19716268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics and resourcing of complex healthcare systems.
    Baghbanian A; Torkfar G
    Aust Health Rev; 2012 Nov; 36(4):394-400. PubMed ID: 22958896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doing more harm than good? Do systematic reviews of PET by health technology assessment agencies provide an appraisal of the evidence that is closer to the truth than the primary data supporting its use?
    Ware RE; Hicks RJ
    J Nucl Med; 2011 Dec; 52 Suppl 2():64S-73S. PubMed ID: 22144557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conducting cost-effectiveness analyses of type 2 diabetes in low- and middle-income countries: can locally generated observational study data overcome methodological limitations?
    Baik S; Chacra AR; Yuxiu L; White J; Güler S; Latif ZA
    Diabetes Res Clin Pract; 2010 May; 88 Suppl 1():S17-22. PubMed ID: 20466164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation and mental health: sparse past. fertile future?
    Knapp M
    J Ment Health Policy Econ; 1999 Dec; 2(4):163-167. PubMed ID: 11967427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellence in the United Kingdom: a game of two halves?
    Drummond MF; Iglesias CP; Cooper NJ
    Int J Technol Assess Health Care; 2008; 24(2):146-50. PubMed ID: 18400116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A guide to health economic evaluations.
    Drug Ther Bull; 2010 Sep; 48(9):105-8. PubMed ID: 20810710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis in pharmacogenomics.
    Payne K; Shabaruddin FH
    Pharmacogenomics; 2010 May; 11(5):643-6. PubMed ID: 20415553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.